SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Stevenson, V L
Right arrow Articles by Miller, D H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevenson, V L
Right arrow Articles by Miller, D H
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosis

V L Stevenson

NMR Research Unit, Institute of Neurology, Queen Square, London, WC1N 3BG, UK

D H Miller

NMR Research Unit, Institute of Neurology, Queen Square, London, WC1N 3BG, UK

Disease progression and irreversible disability in multiple sclerosis results from incomplete recovery from relapses, but most importantly from insidious disease progression. Although magnetic resonance imaging parameters, such as new lesion rate and gadolinium enhancement, reflect inflammation and disease activity they have no bearing on disease progression. Until now the T2 lesion load or disease burden has been relied upon for this, despite its poor relationship with disability measures. This paper looks at the mechanisms responsible for disease progression and discusses the MR techniques now available to reflect these pathological processes.

Key Words: multiple sclerosis • magnetic resonance imaging

Multiple Sclerosis, Vol. 5, No. 4, 268-272 (1999)
DOI: 10.1177/135245859900500413


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
R. Dutta and B. D. Trapp
Pathogenesis of axonal and neuronal damage in multiple sclerosis
Neurology, May 29, 2007; 68(22_suppl_3): S22 - S31.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Oh, R G Henry, C Genain, S J Nelson, and D Pelletier
Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging
J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1281 - 1286.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
C. Lucchinetti and W. Bruck
The pathology of primary progressive multiple sclerosis
Multiple Sclerosis, June 1, 2004; 10(1_suppl): S23 - S30.
[Abstract] [PDF]


Home page
Mult SclerHome page
C. Lucchinetti and W. Bruck
The pathology of primary progressive multiple sclerosis
Multiple Sclerosis, May 1, 2004; 10(3_suppl): S23 - S30.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Wilson, C R Tench, P S Morgan, and L D Blumhardt
Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability
J. Neurol. Neurosurg. Psychiatry, February 1, 2003; 74(2): 203 - 207.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
E. R. Melhem, E. H. Herskovits, K. Karli-Oguz, X. Golay, D. A. Hammoud, B. J. Fortman, F. M. Munter, and R. Itoh
Defining Thresholds for Changes in Size of Simulated T2-Hyperintense Brain Lesions on the Basis of Qualitative Comparisons
Am. J. Roentgenol., January 1, 2003; 180(1): 65 - 69.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. L. Arnold and P.M. Matthews
MRI in the diagnosis and management of multiple sclerosis
Neurology, April 23, 2002; 58(90084): S23 - 31.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
F. Bonneville, D. M. Moriarty, B. S.Y. Li, J. S. Babb, R. I. Grossman, and O. Gonen
Whole-Brain N-Acetylaspartate Concentration: Correlation with T2-Weighted Lesion Volume and Expanded Disability Status Scale Score in Cases of Relapsing-Remitting Multiple Sclerosis
AJNR Am. J. Neuroradiol., March 1, 2002; 23(3): 371 - 375.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Wilson, P S Morgan, X Lin, B P Turner, and L D Blumhardt
Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, March 1, 2001; 70(3): 318 - 322.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. T. Phillips
Rethinking Multiple Sclerosis
Arch Neurol, January 1, 2001; 58(1): 30 - 32.
[Full Text] [PDF]



Advertisement